Edition:
United States

Monsanto Co (MON.N)

MON.N on New York Stock Exchange

106.77USD
4:01pm EDT
Change (% chg)

$0.65 (+0.61%)
Prev Close
$106.12
Open
$106.09
Day's High
$107.07
Day's Low
$105.67
Volume
454,942
Avg. Vol
919,623
52-wk High
$113.20
52-wk Low
$81.22

MON.N

Chart for MON.N

About

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity. Through its... (more)

Overall

Beta: 1.21
Market Cap(Mil.): $46,435.52
Shares Outstanding(Mil.): 437.58
Dividend: 0.54
Yield (%): 2.04

Financials

  MON.N Industry Sector
P/E (TTM): 44.65 23.35 45.84
EPS (TTM): 2.38 -- --
ROI: 6.23 6.20 68.37
ROE: 15.05 7.11 79.12

USDA confirms unapproved GMO wheat found in Washington state

Genetically modified wheat developed by Monsanto Co, and never approved by federal regulators, has been found growing in a Washington state farm field, the U.S. Department of Agriculture (USDA) said on Friday.

3:25pm EDT

UPDATE 2-USDA confirms unapproved GMO wheat found in Washington state

July 29 Genetically modified wheat developed by Monsanto Co, and never approved by federal regulators, has been found growing in a Washington state farm field, the U.S. Department of Agriculture (USDA) said on Friday.

3:23pm EDT

BRIEF-Bayer CFO says no need to rush into Covestro share sale

* CFO Johannes Dietsch says no need to rush into any Covestro share sale transaction, no need to pile up further cash at the moment

Jul 27 2016

BASF CEO says not parting with crop protection division

FRANKFURT, July 27 BASF will not put its Agricultural Solutions unit up for sale as part of an ongoing consolidation wave in the crop protection and seeds industry, the chemical group's chief executive said on Wednesday.

Jul 27 2016

Bayer drugs secure earnings beat, offset weak crop chems

FRANKFURT Bayer , the German drugmaker trying to acquire U.S. seed company Monsanto , surpassed second-quarter earnings expectations and raised its guidance for the year as strong gains in stroke prevention pill Xarelto offset sluggish farming pesticides markets.

Jul 27 2016

EU approves Monsanto, Bayer genetically modified soybeans

CHICAGO The European Commission on Friday approved imports of Monsanto's Roundup Ready 2 Xtend genetically modified soybean variety, after months of delays that had derailed the U.S. seed giant's product launch this spring.

Jul 22 2016

UPDATE 3-EU approves Monsanto, Bayer genetically modified soybeans

* Authorisation for feed, food use but not cultivation (Recasts throughout; adds ADM comment, analyst comment, Monsanto share prices)

Jul 22 2016

BRIEF-Monsanto gets European Commission import approval for Roundup Ready 2 xtend soybeans

* European Commission has granted import approval for Roundup Ready 2 xtend soybeans

Jul 22 2016

Monsanto rejects Bayer's sweetened offer, open to talks

U.S. seed company Monsanto Co turned down a sweetened $64 billion acquisition offer from Bayer AG , but said it was open to further talks with the German healthcare and chemicals group as well as other parties.

Jul 19 2016

UPDATE 6-Monsanto rejects Bayer's sweetened offer, open to talks

* Monsanto shares rise 0.3 pct; Bayer off 1.2 pct (Adds Bayer statement, updates shares)

Jul 19 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Stock Traders Daily
$20.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.